Related Experiment Video
Updated: Jan 7, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
Hereditary thrombophilia parameters in children with autism spectrum disorder and their mothers
Perihan Cam Ray1, Merve Doğan1, Sevcan Bozdoğan2
1Department of Child and Adolescent Psychiatry, Cukurova University Faculty of Medicine, Adana, Türkiye.
Insights
The FXIII-Val34Leu gene variant was more common in children with Autism Spectrum Disorder (ASD) and their mothers, increasing ASD risk. Further research is needed to explore thrombophilia markers in ASD.
Area of Science:
- Neuroscience
- Genetics
- Pediatrics
Background:
- Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with known genetic and environmental influences.
- Emerging evidence suggests a potential link between hereditary thrombophilia and ASD, possibly due to placental issues and neuroinflammation.
- Thrombophilia, a condition increasing blood clot risk, involves genetic factors that may impact pregnancy and fetal development.
Purpose of the Study:
- To investigate the frequency of specific thrombophilia-related genetic polymorphisms in children diagnosed with ASD and their mothers.
- To determine if these genetic variations are associated with an increased risk of developing ASD.
- To explore potential links between maternal thrombophilia and ASD in offspring.
Main Methods:
- A case-control study comparing 24 children with ASD (ages 2-6) and their mothers to 24 age-matched healthy children and their mothers.
- Genetic analysis using PCR to detect thrombophilia polymorphisms: FVL G1691A, FII G20210A, MTHFR C677T, MTHFR 1298AC, FXIII-Val34Leu, and PAI-1 4G/5G.
- Statistical analyses, including logistic regression, were used to evaluate associations between polymorphisms and ASD, controlling for relevant factors.
Main Results:
- The FXIII-Val34Leu heterozygous variant was significantly more prevalent in children with ASD (37.5%) and their mothers (54.2%) compared to controls (8.3% and 16.7%, respectively).
- Logistic regression indicated that the FXIII-Val34Leu heterozygous polymorphism in either mother or child increased the odds of ASD by approximately 4.130-fold.
- No significant differences were found for other tested thrombophilia polymorphisms between ASD cases and controls. Children with ASD also showed developmental delays.
Conclusions:
- The FXIII Val34Leu mutation is notably more frequent in children with ASD and their mothers, suggesting a potential genetic risk factor.
- This finding highlights the FXIII Val34Leu polymorphism as a potential marker for ASD risk.
- Further large-scale, longitudinal studies are essential to confirm these findings and explore the role of thrombophilia markers in ASD pathogenesis.
Objective:
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition influencyed by genetic and environmental factors. There is emerging evidence of an association between hereditary thrombophilia and ASD, potentially mediated by impaired placental perfusion and resultant neuroinflammatory processes. This study aimed to investigate the frequency of thrombophilia-related genetic polymorphisms in children diagnosed with ASD and their mothers.
Methods:
A total of 24 children with ASD aged 2-6 and their mothers were compared with 24 age-matched healthy children and their mothers. Sociodemographic, developmental and genetic data were collected. A psychiatric evaluation was performed according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and the children were assessed using the Autism Behavior Checklist (ABC), the Modified Checklist for Autism in Toddlers (M-CHAT) and the Ankara Developmental Screening Inventory (ADSI). Thrombophilia-related polymorphisms, including FVL G1691A, FII G20210A, C677T MTHFR and 1298AC MTHFR, FXIII-Val34Leu and PAI-1 4G/5G, were analyzed using PCR-based methods. Statistical comparisons and logistic regression analyses were performed to evaluate associations with ASD.
Results:
The FXIII-Val34Leu heterozygous variant was significantly more prevalent in children with ASD (37.5% vs. 8.3%, p = 0.036) and their mothers (54.2% vs. 16.7%, p = 0.015) than in the control group. Logistic regression analysis revealed that the presence of the FXIII-Val34Leu heterozygous polymorphism in either the mother or child was associated with an approximately 4.130-fold increase in the odds of ASD (adjusted odds ratio = 4.130, 95% confidence interval = 1.180-5.300, p = 0.027). Other thrombophilia polymorphisms did not differ significantly between groups. Additionally, children with ASD exhibited significant delays in speech development and lower developmental scores across several domains.
Conclusion:
This study is among the first to examine the FXIII Val34Leu mutation in children with ASD and their mothers. Further large-scale, longitudinal studies are needed to investigate thrombophilia markers in relation to ASD.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Pedigree Analysis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Probability Laws
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

